Rapporto sull’analisi delle dimensioni del mercato e dell’analisi delle quote dei farmaci contro il cancro gastrointestinale | Previsioni 2031

  • Report Code : TIPRE00020036
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Gastrointestinal Cancer Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

INTRODUZIONE AL MERCATO

Il cancro gastrointestinale è una condizione del tratto gastrointestinale e di tutti gli organi associati del tratto digestivo che includono stomaco, esofago, sistema biliare, pancreas, intestino tenue e crasso e retto. Il segno e i sintomi del cancro gastrointestinale dipendono dall'organo del tratto interessato, ma i sintomi più comuni includono sanguinamento insolito, ostruzione, disagio, emorragia, dolore addominale ecc. I farmaci contro il cancro gastrointestinale sono gli agenti terapeutici utilizzati nella gestione della malattia .

DINAMICHE DEL MERCATO

I principali driver di mercato per il mercato dei farmaci contro il cancro gastrointestinale sono, l’aumento della prevalenza dei tumori gastrointestinali, l’aumento della consapevolezza sulla diagnosi del cancro e la sua trattamento, crescente domanda di terapie farmacologiche mirate. Inoltre, si prevede che i progressi nelle terapie farmacologiche contro il cancro con il lancio di NDDS alimenteranno la crescita del mercato durante il periodo di previsione. Tuttavia, si prevede che gli elevati costi associati allo sviluppo del farmaco e la prevalenza degli effetti collaterali freneranno la crescita del mercato durante il periodo di previsione.

AMBITO DI MERCATO

Il "Mercato dei farmaci contro il cancro gastrointestinale" è uno studio specializzato e approfondito dell'industria farmaceutica con particolare attenzione al analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato Farmaci contro il cancro gastrointestinale con una segmentazione completa del mercato per terapia, applicazione e utente finale. Si prevede che il mercato Farmaci contro il cancro gastrointestinale assisterà a una crescita elevata durante il periodo di previsione. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori nel mercato Farmaci contro il cancro gastrointestinale e offre tendenze e opportunità chiave nel mercato.

SEGMENTAZIONE DEL MERCATO

Il mercato dei farmaci contro il cancro gastrointestinale è segmentato sulla base della terapia, dell'applicazione e dell'utente finale. Sulla base della terapia il mercato è diviso in immunoterapia, chemioterapia, terapia mirata, terapia ormonale, radioterapia e altre. In base all’applicazione il mercato è segmentato in oncologia, radiologia e altri. E sulla base dell'utente finale il mercato è segmentato in ospedali, trattamenti oncologici specializzati, cliniche, altri.

Gastrointestinal Cancer Drugs Market: Strategic Insights

Gastrointestinal Cancer Drugs Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Amgen Limited
  • Bristol Myers Squibb Company
  • F Hoffmann La Roche Ltd
  • Eli Lilly and Company
  • Johnson and Johnson Private Limited
  • GlaxoSmithKline plc
  • Celgene Corporation
  • Pfizer Inc
  • Sanofi

Regional Overview

Regional And Country Scope
  • Nord America
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
  • Medio Oriente e Africa

Market Segmentation

Segment 1Terapia
  • immunoterapia
  • chemioterapia
  • terapia mirata
  • terapia ormonale
  • chemioterapia adiuvante
  • radioterapia
  • altre
Segment2Applicazione
  • Oncologia
  • Radiologia
  • Altro
Segment3Utente finale
  • ospedali
  • centri specializzati nella cura del cancro
  • cliniche
  • centri chirurgici ambulatoriali
Segment4Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale


Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato Farmaci contro il cancro gastrointestinale in base a vari segmenti. Fornisce inoltre stime sulle dimensioni del mercato e sulle previsioni dall’anno 2021 al 2031 rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud & America Centrale. Il mercato Farmaci contro il cancro gastrointestinale in ciascuna regione è successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l'analisi e le previsioni di 18 paesi a livello globale insieme alle tendenze attuali e alle opportunità prevalenti nella regione.

Il rapporto analizza i fattori che influenzano il mercato dei farmaci contro il cancro gastrointestinale sia dal lato della domanda che dell'offerta e valuta ulteriormente le dinamiche del mercato che influenzano il mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud & America Centrale dopo aver valutato i fattori politici, economici, sociali e tecnologici che incidono sul mercato dei farmaci contro il cancro gastrointestinale in queste regioni.

ATTORI DI MERCATO

Il rapporto copre sviluppi chiave nelle strategie di crescita organica e inorganica dei mercati dei farmaci contro il cancro gastrointestinale. Diverse aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altri come brevetti ed eventi. Le strategie di crescita inorganica osservate nel mercato sono state acquisizioni e partnership & collaborazioni. Queste attività hanno aperto la strada all’espansione del business e della base clienti degli operatori del mercato. Si prevede che gli operatori del mercato dei farmaci per il cancro gastrointestinale avranno opportunità di crescita redditizie in futuro con la crescente domanda per il mercato dei farmaci per il cancro gastrointestinale nel mercato globale. Di seguito è riportato l’elenco di alcune aziende impegnate nel mercato dei farmaci per il cancro gastrointestinale.

Il rapporto include anche i profili dei principali attori nel mercato dei farmaci per il cancro gastrointestinale insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni, sviluppi chiave negli ultimi cinque anni.

    •  Amgen Limited •  Azienda Bristol-Myers Squibb •  F. Hoffmann-La Roche Ltd. •  Eli Lilly e compagnia •  Johnson e Johnson •  GlaxoSmithKline Plc. •  Celgene Corporation •  Pfizer, Inc. •  Sanofi •  Novartis AG

Il team di ricerca e analisi dedicato del partner Insight è composto da professionisti esperti con competenze statistiche avanzate e offre varie opzioni di personalizzazione nello studio esistente.

Gastrointestinal Cancer Drugs Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Terapia
  • immunoterapia
  • chemioterapia
  • terapia mirata
  • terapia ormonale
  • chemioterapia adiuvante
  • radioterapia
  • altre
By Applicazione
  • Oncologia
  • Radiologia
  • Altro
By Utente finale
  • ospedali
  • centri specializzati nella cura del cancro
  • cliniche
  • centri chirurgici ambulatoriali
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Amgen Limited
  • Bristol Myers Squibb Company
  • F Hoffmann La Roche Ltd
  • Eli Lilly and Company
  • Johnson and Johnson Private Limited
  • GlaxoSmithKline plc
  • Celgene Corporation
  • Pfizer Inc
  • Sanofi
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Amgen Limited
    2. Bristol-Myers Squibb Company
    3. F. Hoffmann-La Roche Ltd
    4. Eli Lilly and Company
    5. Johnson and Johnson Private Limited
    6. GlaxoSmithKline plc
    7. Celgene Corporation
    8. Pfizer Inc
    9. Sanofi
    10. Novartis AG

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..